Abstract

The interaction of P6-2VIR576, a peptide derived from the GBV-C E2 structural protein, with anionic lipid membranes (DMPC:DMPS (3:2) and DPPC:DPPS (3:2)) and its effect on HIV-1 fusion peptide (HIV-1 FP) binding with the membrane were studied. P6-2VIR576 showed higher surface activity than its parent peptide AcP6-2, with an area per molecule value in π-A compression isotherms approximately twice that of AcP6-2. Interaction studies, involving penetration experiments in lipid monolayers and lipid bilayer binding assays, demonstrated that P6-2VIR576 interacted better with the more rigid membrane DPPC:DPPS (3:2), with an exclusion pressure slightly lower than the biological membrane pressure (24–30mNm−1). This, together with the results of the binding experiments and considering the effect of ionic strength and changes in membrane dipole potential, indicate a lipid-peptide interaction driven by electrostatic forces followed by hydrophobic interactions. Morphological surface analysis by fluorescence microscopy of Langmuir-Blodgett monolayers revealed that P6-2VIR576 suppressed the interaction of HIV-1 FP with the membrane.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.